IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to shrink tough colon cancers before surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy before surgery can help people with a common type of colon cancer (MSS, locally advanced). About 60 adults will receive the combination, then have surgery to remove the tumor. The main go…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New study reveals how immunotherapy works for american indian cancer patients
Knowledge-focused OngoingThis study looks back at medical records of 72 American Indian adults with cancers like lung, melanoma, and kidney who received immunotherapy. Researchers compare their outcomes, such as cancer progression and side effects, to those of White patients. The goal is to spot any diff…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated May 17, 2026 09:06 UTC